Skip Navigation


American Journal of Epidemiology Advance Access originally published online on July 20, 2005
American Journal of Epidemiology 2005 162(4):305-317; doi:10.1093/aje/kwi202
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
162/4/305    most recent
kwi202v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (45)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lehmann, D. J.
Right arrow Articles by Kehoe, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehmann, D. J.
Right arrow Articles by Kehoe, P. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Copyright © 2005 by the Johns Hopkins Bloomberg School of Public Health All rights reserved

META-ANALYSIS

Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease

Donald J. Lehmann1, Mario Cortina-Borja2, Donald R. Warden1, A. David Smith1, Kristel Sleegers3, Jonathan A. Prince4, Cornelia M. van Duijn3 and Patrick G. Kehoe5

1 The Oxford Project to Investigate Memory and Ageing (OPTIMA), Department of Pharmacology, University of Oxford, Oxford, United Kingdom
2 Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, University College London, London, United Kingdom
3 Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, the Netherlands
4 Center for Genomics and Bioinformatics, Karolinska Institute, Stockholm, Sweden
5 Care of the Elderly, Department of Clinical Science at North Bristol, University of Bristol, Frenchay Hospital, Bristol, United Kingdom

Correspondence to D. J. Lehmann, University Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, United Kingdom (e-mail: donald.lehmann{at}pharm.ox.ac.uk).

Apolipoprotein E {varepsilon}4 (APOE*4) is the only fully established susceptibility allele for Alzheimer's disease. One of the most studied candidates is the insertion (I)/deletion (D) polymorphism (indel) of the gene for angiotensin I-converting enzyme (ACE). This study aimed to clarify its association with Alzheimer's disease. The meta-analysis included 39 samples, comprising 6,037 cases of Alzheimer's disease and 12,099 controls, using mainly primary data. Potential interactions with gender, age, ethnic group, and carrier status of the apolipoprotein E {varepsilon}4 allele were all examined. D homozygotes were at reduced risk of Alzheimer's disease (odds ratio = 0.81, 95% confidence interval: 0.72, 0.90; corrected p = 0.0004); I homozygotes showed no association with Alzheimer's disease, while heterozygotes were at increased risk. Although there were clear differences among the three ethnic groups examined (North Europeans, South Caucasians, and East Asians), in all groups D homozygotes were at reduced risk. These results confirm the association of the angiotensin I-converting enzyme indel with Alzheimer's disease across diverse populations, although this is probably due to linkage disequilibrium with the true risk factor. Further, in North Europeans, both association and Hardy-Weinberg analysis suggested partial heterosis, that is, an increased risk for heterozygotes, due to a hidden interaction with another, as yet unknown, risk factor. This interaction warrants further investigation.

Alzheimer disease; heterogeneity; meta-analysis


Abbreviations: ACE, angiotensin I-converting enzyme (protein); ACE, angiotensin I-converting enzyme (gene); APOE*4, apolipoprotein E {varepsilon}4 (allele)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Age AgeingHome page
H.A.D. Keage, F.E. Matthews, A. Yip, L. Gao, C. McCracken, I.G. McKeith, D.C. Rubinsztein, C. Brayne, and MRC Cognitive Function and Ageing Study
APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study
Age Ageing, November 24, 2009; (2009) afp210v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Zou, T. Maeda, A. Watanabe, J. Liu, S. Liu, R. Oba, Y.-i. Satoh, H. Komano, and M. Michikawa
A{beta}42-to-A{beta}40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
J. Biol. Chem., November 13, 2009; 284(46): 31914 - 31920.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
A V September, J Cook, C J Handley, L van der Merwe, M P Schwellnus, and M Collins
Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations
Br. J. Sports Med., May 1, 2009; 43(5): 357 - 365.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
Hua Liu, Ming Liu, Wei Li, Bo Wu, S.-h. Zhang, Yuan Fang, and Yi Wang
Association of ACE I/D Gene Polymorphism With Vascular Dementia: A Meta-Analysis
J Geriatr Psychiatry Neurol, March 1, 2009; 22(1): 10 - 22.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
E. Zintzaras, G. Raman, G. Kitsios, and J. Lau
Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphic Variant as a Marker of Coronary Artery Disease: A Meta-analysis
Arch Intern Med, May 26, 2008; 168(10): 1077 - 1089.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
I. M. Hajjar, M. Keown, P. Lewis, and A. Almor
Angiotensin Converting Enzyme Inhibitors and Cognitive and Functional Decline in Patients with Alzheimer's Disease: An Observational Study
American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 77 - 83.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
K. Zou, H. Yamaguchi, H. Akatsu, T. Sakamoto, M. Ko, K. Mizoguchi, J.-S. Gong, W. Yu, T. Yamamoto, K. Kosaka, et al.
Angiotensin-Converting Enzyme Converts Amyloid {beta}-Protein 1 42 (A{beta}1 42) to A{beta}1 40, and Its Inhibition Enhances Brain A{beta} Deposition
J. Neurosci., August 8, 2007; 27(32): 8628 - 8635.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Ellul, N Archer, C M L Foy, M Poppe, H Boothby, H Nicholas, R G Brown, and S Lovestone
The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration
J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 233 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Eckman, S. K. Adams, F. J. Troendle, B. A. Stodola, M. A. Kahn, A. H. Fauq, H. D. Xiao, K. E. Bernstein, and C. B. Eckman
Regulation of Steady-state beta-Amyloid Levels in the Brain by Neprilysin and Endothelin-converting Enzyme but Not Angiotensin-converting Enzyme
J. Biol. Chem., October 13, 2006; 281(41): 30471 - 30478.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F.A. Sayed-Tabatabaei, B.A. Oostra, A. Isaacs, C.M. van Duijn, and J.C.M. Witteman
ACE Polymorphisms
Circ. Res., May 12, 2006; 98(9): 1123 - 1133.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Hemming and D. J. Selkoe
Amyloid {beta}-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
J. Biol. Chem., November 11, 2005; 280(45): 37644 - 37650.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.